Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
The CGMS in GDM Labor and Delivery Study

level. Modern continuous glucose monitoring (CGM) systems can capture the direction and magnitude of short-lived changes in interstitial glucose levels and are therefore useful for assessing glucose

Accepts healthy volunteers
  • 0 views
  • 02 Dec, 2021
  • 1 location
Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes (CRISTAL)

Multi-centric open-label randomized controlled trial (RCT) with 11 Belgian centers and one Dutch center in pregnant women with type 1 diabetes to assess safety, efficacy, feasibility and cost-effectiveness of 780 MiniMed Medtronic hybrid closed-loop insulin system (intervention group) compared to standard of care therapy (control group).

  • 0 views
  • 26 May, 2022
  • 12 locations
Insulin Titration System Based on Deep Learning

This is an open-labeled, one-arm intervention trial to access the effect and safety of the Insulin Titration System Based on Deep Learning in patients with Type 2 Diabetes Mellitus.

  • 0 views
  • 14 Jun, 2022
  • 1 location
Chinese Smartphone App for 6-18 Years With T1DM - RCT

Moving into the era of electronic communication, it changes the way we shall engage our children and adolescents. According to data of the Census and Statistics Department of Hong Kong releases in 2019, more than 80% and up to 99.4% of those aged 10-14 years, and aged 15-24 years respectively …

  • 0 views
  • 05 Jul, 2022
  • 1 location
A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

This double-masked placebo-controlled study will include approximately 450 subjects with inadequately controlled T2DM on diet control alone or on diet control and metformin monotherapy. Subjects will undergo an initial 21-day Screening Period, followed by a 26-week Double-Blind Treatment Period and a Double-Blind 26-week Treatment Extension Period.

  • 0 views
  • 02 May, 2022
  • 1 location
Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS) (Cyber GEMS)

Given the known serious consequences of uncontrolled blood sugars during hospitalization, this research plans to study an alternative seamlessly integrated continuous glucose monitoring (CGM

continuous glucose monitoring
sugars
insulin
hemoglobin a1c
hypoglycemic agents
  • 0 views
  • 04 Oct, 2022
  • 1 location
Dietary Strategies for Remission of Type 2 Diabetes (CARBCOUNT)

-in-range measured by continuous glucose monitoring) and other factors such as anthropometric changes and genetic susceptibility. Each center will also conduct locally-lead standalone mechanistic

diabetes
cardiovascular disease
  • 0 views
  • 04 Oct, 2022
  • 1 location
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (Protocol AF)

risk for side effects that adversely affect visual function. This study will also assess the relationship of glycemic variability, as measured by continuous glucose monitoring with DR outcomes

pupil dilation
insulin
diabetes
microaneurysms
severe nonproliferative diabetic retinopathy
  • 35 views
  • 20 Sep, 2022
  • 45 locations
Continuous Glucose Monitoring Following Hospital Discharge

In this 12-week prospective observational cohort study, hospitalized insulin-requiring patients with T2D will receive a Dexcom continuous glucose monitor (CGM) to wear post-hospital discharge. Patients will complete surveys assessing patient-reported outcomes prior to CGM use and following completion of the study. CGM data will be captured by the patient smartphone …

hyperglycemia
continuous glucose monitoring
hemoglobin a1c
insulin
hypoglycemia
  • 0 views
  • 10 May, 2022
  • 1 location
Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT") (CHAT)

necessary. In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic control in Hispanic/Latino (predominantly of Mexican origin) adults with or at-risk of T2D before

  • 0 views
  • 24 Apr, 2022
  • 1 location